Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

711results about How to "Facilitate functioning" patented technology

Integrated routing/mapping information

An Integrated Routing/Mapping Information System (IRMIS) links desktop personal computer cartographic applications to one or more handheld organizer, personal digital assistant (PDA) or "palmtop" devices. Such devices may be optionally equipped with, or connected to, portable Global Positioning System (GPS) or equivalent position sensing device. Desktop application facilitates user selection of areas, starts, stops, destinations, maps and/or point and/or route information. It optionally includes supplemental online information, preferably for transfer to the PDA or equivalent device. Users' options include route information, area, and route maps. Maps and related route information are configured with differential detail and levels of magnitude. Used in the field, in conjunction with GPS receiver, the PDA device is configured to display directions, text and map formats, the user's current position, heading, speed, elevation, and so forth. Audible signals identifying the next turn along the user's planned route are also provided. The user can pan across maps and zoom between two or more map scales, levels of detail, or magnitudes. The IRMIS also provides for "automatic zooming," e.g., to show greater detail or closer detail as the user approaches a destination, or to larger scale and lower resolution to show the user's overall planned route between points of interest. The IRMIS also enables the user to mark or record specific locations and/or log actual travel routes, using GPS position information. These annotated location marks and/or "breadcrumb" or GPS log data can be saved, uploaded, displayed, or otherwise processed on the user's desktop geographic information or cartographic system. The IRMIS application and data may be distributed online and/or in tangible media in limited and advanced manipulation formats.
Owner:GARMIN

Integrated routing/mapping information system

An Integrated Routing / Mapping Information System (IRMIS) links desktop personal computer cartographic applications to one or more handheld organizer, personal digital assistant (PDA) or "palmtop" devices. Such devices may be optionally equipped with, or connected to, portable Global Positioning System (GPS) or equivalent position sensing device. Desktop application facilitates user selection of areas, starts, stops, destinations, maps and / or point and / or route information. It optionally includes supplemental online information, preferably for transfer to the PDA or equivalent device. Users' options include route information, area, and route maps. Maps and related route information are configured with differential detail and levels of magnitude. Used in the field, in conjunction with GPS receiver, the PDA device is configured to display directions, text and map formats, the user's current position, heading, speed, elevation, and so forth. Audible signals identifying the next turn along the user's planned route are also provided. The user can pan across maps and zoom between two or more map scales, levels of detail, or magnitudes. The IRMIS also provides for "automatic zooming," e.g., to show greater detail or closer detail as the user approaches a destination, or to larger scale and lower resolution to show the user's overall planned route between points of interest. The IRMIS also enables the user to mark or record specific locations and / or log actual travel routes, using GPS position information. These annotated location marks and / or "breadcrumb" or GPS log data can be saved, uploaded, displayed, or otherwise processed on the user's desktop geographic information or cartographic system. The IRMIS application and data may be distributed online and / or in tangible media in limited and advanced manipulation formats.
Owner:KHOURI ANTHONY

Circulatory support system

A method for providing at least partial bypass of the heart to supplement the pumping function of the heart to thereby enable the surgeon to perform various surgical procedures thereon includes providing a circulatory assist system having a portable extracorporeal axial flow pump with a pump housing, a rotating pumping member disposed in the pump housing and inlet and outlet cannulated tubes respectively connected to inlet and outlet ports of the pump housing, accessing the patient's left atrium of the heart with the inlet cannulated tube, accessing the aorta with the outlet cannulated tube, actuating the rotating pumping member to draw oxygenated blood from the left atrium of the heart through the lumen of the inlet cannulated tube and into the inlet port of the pump housing whereby the pumping member imparts mechanical energy to the oxygenated blood passing through the pump housing and directs the oxygenated blood through the outlet port and through the lumen of the outlet cannulated tube to be transferred by the aorta to the systemic arteries and permitting the right side of the heart to function whereby oxygen-depleted blood returning through the systemic veins to the right atrium is directed through the right ventricle to the patient's lungs for oxygenation and subsequent pulmonary circulation.
Owner:UNITED STATES SURGICAL CORP

Programmed-release, nanostructured biological construct

A biologically engineered construct comprising of a polymeric biomatrix, designed with a nanophase texture, and a therapeutic agent for the purpose of tissue regeneration and/or controlled delivery of regenerative factors and therapeutic substances after it is implanted into tissues, vessels, or luminal structures within the body. The therapeutic agent may be a therapeutic substance or a biological agent, such as antibodies, ligands, or living cells. The nanophase construct is designed to maximize lumen size, promote tissue remodeling, and ultimately make the implant more biologically compatible. The nano-textured polymeric biomatrix may comprise one or more layers containing therapeutic substances and/or beneficial biological agents for the purpose of controlled, differential substance/drug delivery into the luminal and abluminal surfaces of the vessel or lumen, and the attraction of target molecules/cells that will regenerate functional tissue. The topographic and biocompatible features of this layered biological construct provides an optimal environment for tissue regeneration along with a programmed-release, drug delivery system to improve physiological tolerance of the implant, and to maximize the cellular survival, migration, and integration within the implanted tissues.
Owner:SCHAPIRA JAY N +1

Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration

A biologically engineered construct comprising of a polymeric biomatrix, designed with a nanophase texture, and a therapeutic agent for the purpose of tissue regeneration and/or controlled delivery of regenerative factors and therapeutic substances after it is implanted into tissues, vessels, or luminal structures within the body. The therapeutic agent may be a therapeutic substance or a biological agent, such as antibodies, ligands, or living cells. The nanophase construct is designed to maximize lumen size, promote tissue remodeling, and ultimately make the implant more biologically compatible. The nano-textured polymeric biomatrix may comprise one or more layers containing therapeutic substances and/or beneficial biological agents for the purpose of controlled, physiological, differential substance/drug delivery into the luminal and abluminal surfaces of the vessel or lumen, and the attraction of target molecules/cells that will regenerate functional tissue. The topographic and biocompatible features of this layered biological construct provides an optimal environment for tissue regeneration along with a programmed-release, drug delivery system to improve physiological tolerance of the implant, and to maximize the cellular survival, migration, and integration within the implanted tissues.
Owner:SCHAPIRA JAY N +1

Polyacrylamide composite flocculant and preparation method thereof

The invention discloses a polyacrylamide composite flocculant and a preparation method thereof. The polyacrylamide composite flocculant is synthesized in situ by the following steps: carrying out inorganic high polymer flocculant surface treatment on acrylamide, an inorganic high polymer flocculant, an initiator, acryloyloxyethyldimethyl long-chain alkyl ammonium bromide and an olefinic-bond-containing silane coupling agent, preparing the polyacrylamide in-situ composite flocculant, and the like. The acrylamide molecule is introduced to the cationic flexible long branched chain structure, so that the physical entanglement network structure can better display the bridge mesh function. By compounding the inorganic high polymer flocculant with the cationic polyacrylamide, the reactive coupling agent is adopted to modify the inorganic high polymer flocculant surface, and the coupling agent molecule participates in the acrylamide polymerization reaction to graft the inorganic high polymer flocculant molecule onto the polyacrylamide molecule, thereby enhancing the interface action between the inorganic high polymer flocculant and polyacrylamide molecule and the adsorption, neutralization, sweep mesh actions on pollutants in sewage.
Owner:四川省科学城天人环保有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products